CORT moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend. In 26 of 34 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 76%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 58 cases where CORT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.
The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CORT as a result. In 51 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 59%.
The Moving Average Convergence Divergence Histogram (MACD) for CORT turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In 24 of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.
CORT broke above its upper Bollinger Band on October 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CORT entered a downward trend on September 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Following a +7.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CORT advanced for three days, in 283 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. CORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.699) is normal, around the industry mean (26.782). CORT has a moderately high P/E Ratio (256.956) as compared to the industry average of (43.395). Projected Growth (PEG Ratio) (2.660) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (15.898) is also within normal values, averaging (437.542).
The Aroon Indicator for TENX entered a downward trend on October 15, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 250 similar instances where the Aroon Indicator formed such a pattern. In 223 of the 250 cases the stock moved lower. This puts the odds of a downward move at 89%.
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TENX as a result. In 76 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TENX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +4.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where TENX advanced for three days, in 189 of 230 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
TENX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.609) is normal, around the industry mean (26.782). P/E Ratio (2.415) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (437.542).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. TENX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TENX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
CORT | TENX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 93 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 42 | 100 | |
SMR RATING 1..100 | 76 | 98 | |
PRICE GROWTH RATING 1..100 | 35 | 95 | |
P/E GROWTH RATING 1..100 | 4 | 80 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TENX's Valuation (38) in the Medical Specialties industry is somewhat better than the same rating for CORT (99) in the Pharmaceuticals Other industry. This means that TENX’s stock grew somewhat faster than CORT’s over the last 12 months.
CORT's Profit vs Risk Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for TENX (100) in the Medical Specialties industry. This means that CORT’s stock grew somewhat faster than TENX’s over the last 12 months.
CORT's SMR Rating (76) in the Pharmaceuticals Other industry is in the same range as TENX (98) in the Medical Specialties industry. This means that CORT’s stock grew similarly to TENX’s over the last 12 months.
CORT's Price Growth Rating (35) in the Pharmaceuticals Other industry is somewhat better than the same rating for TENX (95) in the Medical Specialties industry. This means that CORT’s stock grew somewhat faster than TENX’s over the last 12 months.
CORT's P/E Growth Rating (4) in the Pharmaceuticals Other industry is significantly better than the same rating for TENX (80) in the Medical Specialties industry. This means that CORT’s stock grew significantly faster than TENX’s over the last 12 months.
| CORT | TENX | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 59% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 71% | N/A |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 81% | 2 days ago 88% |
| Advances ODDS (%) | 12 days ago 84% | 15 days ago 82% |
| Declines ODDS (%) | 2 days ago 63% | 2 days ago 87% |
| BollingerBands ODDS (%) | 2 days ago 62% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 43% | 2 days ago 89% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CORT’s FA Score shows that 1 FA rating(s) are green while TENX’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CORT’s TA Score shows that 1 TA indicator(s) are bullish while TENX’s TA Score has 4 bullish TA indicator(s).
CORT (@Biotechnology) experienced а -4.36% price change this week, while TENX (@Biotechnology) price change was -18.82% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.70%. For the same industry, the average monthly price growth was -18.24%, and the average quarterly price growth was -21.46%.
CORT is expected to report earnings on Nov 04, 2026.
TENX is expected to report earnings on Nov 18, 2026.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CRWU | 21.33 | 2.24 | +11.76% |
| T-REX 2X Long CRWV Daily Target ETF | |||
| TDVG | 49.89 | 0.41 | +0.84% |
| T. Rowe Price Dividend Growth ETF (TDVG) | |||
| EMHC | 24.11 | 0.15 | +0.63% |
| State Street SPDR Bloomberg Emerging Markets USD Bond ETF (EMHC) | |||
| PSMR | 33.03 | N/A | N/A |
| Pacer Swan SOS Moderate (April) ETF (PSMR) | |||
| EXEQ | 26.40 | N/A | N/A |
| Wedbush ReturnOnLeadership U.S. Large-Cap ETF (EXEQ) | |||
A.I.dvisor indicates that over the last year, TENX has been closely correlated with SION. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if TENX jumps, then SION could also see price increases.
| Ticker / NAME | Correlation To TENX | 1D Price Change % | ||
|---|---|---|---|---|
| TENX | 100% | -1.63% | ||
| SION - TENX | 93% Closely correlated | -0.24% | ||
| AVXL - TENX | 47% Loosely correlated | -0.67% | ||
| CORT - TENX | 41% Loosely correlated | -2.46% | ||
| HRTX - TENX | 40% Loosely correlated | +4.01% | ||
| MGNX - TENX | 32% Poorly correlated | +1.81% | ||
More | ||||